Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent β-thalassemia: a comprehensive single-center experience
Author:
Funder
vice-chancellor for research, shiraz university of medical sciences
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-021-04627-4.pdf
Reference39 articles.
1. Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12(2):61–76
2. Taher AT, Musallam KM, Cappellini MD (2021) β-Thalassemias. N Engl J Med 384(8):727–743
3. Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A (2014) Guidelines for diagnosis and management of Beta-thalassemia intermedia. Pediatr Hematol Oncol 31(7):583–596. https://doi.org/10.3109/08880018.2014.937884
4. Musallam KM, Cappellini MD, Daar S, Taher AT (2021) Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study. Ann Hematol. https://doi.org/10.1007/s00277-020-04370-2
5. Musallam KM, Cappellini MD, Taher AT (2021) Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia. Ann Hematol 100(7):1903–1905
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study;Scientific Reports;2023-08-21
2. Hydroxyurea attenuates hepatic stellate cell proliferation in vitro and liver fibrogenesis in vivo;The FASEB Journal;2023-08-08
3. An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment;Hemoglobin;2023-03-04
4. Non-Transfusion-Dependent Thalassemia: A Panoramic Review;Medicina;2022-10-21
5. Investigating the Efficacy and Safety of Thalidomide for Treating Patients With ß-Thalassemia: A Meta-Analysis;Frontiers in Pharmacology;2022-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3